Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECs for CIED Placement
NCT05283980Phase 3Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Nov 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Beth Israel Deaconess Medical Center. Started Nov 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05283980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283980.